Products

Sonio Suspect
Sonio
OB/GYN AI
Sonio Suspect is an FDA-cleared AI ultrasound module that improves prenatal diagnostics by enhancing fetal anomaly detection and enabling earlier identification of congenital malformations, integrated into Sonio's cloud-based reporting and workflow solution.
Sonio Detect
Sonio
OB/GYN AI
Sonio Detect is an FDA 510(k) cleared AI-powered software for prenatal ultrasound, enhancing efficiency and quality control in OB-GYN and MFM practices with automated reporting, real-time feedback, and streamlined image management.

See all 2 products →

About Sonio

Sonio is a healthcare AI company that specializes in developing advanced software solutions for prenatal ultrasound examinations. Their platform, which includes FDA 510(k) cleared AI enhancement through its Sonio Detect product, is designed to empower ultrasound practitioners by providing a comprehensive workflow and practice management solution. The technology aims to enhance the efficiency and quality of prenatal care by assisting in the detection of congenital malformations, offering real-time feedback on image quality, automating reporting, and streamlining clinical workflows.

For physicians, Sonio’s AI-powered software integrates seamlessly into existing systems (such as PACS, FAX, and EHR) and is compatible with all ultrasound machines, ensuring a smooth transition and enhanced operational efficiency. The platform provides built-in quality control, automatic population of report fields, and AI-assisted exams that offer instant feedback on image quality, promoting informed clinical decision-making and ensuring the completeness of each examination. Sonio’s mission is to improve women’s and children’s health globally by promoting access and quality of care through technological innovation, medical expertise, and collective intelligence.

Sonio was acquired by Samsung Medison Co., Ltd. in 2024, with the acquisition finalized on August 30, 2024. Despite the acquisition, Sonio is expected to remain an independent company headquartered in France, continuing its commercial growth and ensuring its products and services remain compatible with various ultrasound device manufacturers.

Focus Areas

Prenatal care maternal-fetal medicine obstetrics and gynecology ultrasound AI-powered ultrasound reporting fetal anomaly detection workflow solutions quality control image management clinical decision support

Business Intelligence

Key InvestorsElaia, Bpifrance French Tech Seed, OneRagtime, Cross Border Impact Ventures, EIC Fund, Dominique Gaillard, Alain Decombe, Yann Fleureau
PartnershipsPediatrix Medical Group, Necker-Enfants Malades University Hospital, MFine, Manager Systems, Samsung Healthcare
AcquisitionsAcquired by Samsung Medison (May 8, 2024; deal closed August 30, 2024 / September 2, 2024) for $92.7M / €86M
TechnologyCloud-based SaaS, machine-agnostic, interoperable, AI-powered (deep learning, probabilistic clinical decision support), real-time feedback, quality control, automation, secure collaboration, HIPAA/HDS/SOC2 Type 2 compliant, integrates with HIS/EMR (HL7, FHIR), compatible with all ultrasound manufacturers (DICOM, DICOM SR, DICOM WL)
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

Prenatal Care & Maternal-Fetal Medicine
Sonio specializes in enhancing high-quality prenatal care, maternal-fetal medicine, obstetrics, and gynecology ultrasound. Their mission is to improve women's and children's health by promoting access and quality of care globally through technological innovation and medical expertise.
AI-Powered Ultrasound Reporting
The company offers cloud-based, AI-powered ultrasound reporting software that automates field population based on ultrasound findings, streamlines report generation, and provides customizable templates.
Fetal Anomaly Detection
Sonio's FDA-cleared clinical AI, Sonio Detect and Sonio Suspect, significantly improves the early and accurate detection of fetal anomalies, addressing a critical gap where up to 51% of anomalies are often missed in standard screenings.
Workflow Solutions & Image Management
They provide comprehensive workflow and practice management solutions, including automated image management, sorting of views, and extraction of best clips from cine-loops, simplifying exam review and reducing manual tasks.
Quality Control & Clinical Decision Support
Sonio incorporates built-in AI-driven quality control that offers instant feedback on image quality, verifies exam completeness against pre-defined criteria, and supports informed clinical decision-making.
Physician Tip

For physicians, Sonio offers a transformative approach to prenatal care by significantly enhancing diagnostic accuracy and enabling earlier detection of fetal anomalies, potentially as early as 11 weeks' gestation. The AI-powered tools streamline reporting, automate image management, and provide real-time feedback, drastically reducing administrative burden and improving workflow efficiency. This allows OB-GYNs and Maternal-Fetal Medicine specialists to focus more on patient care and less on manual tasks, while ensuring consistent, high-quality exams across their practice through standardized protocols and AI-verified completeness. The cloud-based platform also facilitates seamless collaboration and remote access to patient data, supporting integrated care and timely consultations.

Sonio is designed for seamless integration with existing healthcare systems, including PACS, FAX, EHR (via HL7, FHIR & Custom integrations), EMR, and billing systems (CPT & ICD10). It is also vendor-neutral, ensuring compatibility with all ultrasound machines.

Products by Sonio

2 products in the directory

Sonio Suspect
Sonio
OB/GYN AI
Sonio Suspect is an FDA-cleared AI ultrasound module that improves prenatal diagnostics by enhancing fetal anomaly detection and enabling earlier identification of congenital malformations, integrated into Sonio's cloud-based reporting and workflow solution.
Sonio Detect
Sonio
OB/GYN AI
Sonio Detect is an FDA 510(k) cleared AI-powered software for prenatal ultrasound, enhancing efficiency and quality control in OB-GYN and MFM practices with automated reporting, real-time feedback, and streamlined image management.

What the Web Says

Sonio is an AI-powered cloud-native platform primarily focused on revolutionizing prenatal care by standardizing and automating fetal ultrasound workflows. It aims to improve women's and children's health by promoting access and quality of care through technological innovation, medical expertise, and collective intelligence. Reviews suggest it's a game-changer for healthcare organizations, streamlining workflows, enhancing diagnostic accuracy, and improving patient outcomes. The company also offers Sonio Voice, a voice-operated assistant for prenatal ultrasound reporting.

Overall: Positive

Strengths

  • Streamlines workflow and enhances diagnostic accuracy in prenatal care.
  • Provides built-in quality control and real-time feedback for sonographers.
  • Offers seamless integration with existing systems like PACS, FAX, and EHR.
  • Cloud-based accessibility allows healthcare professionals to access examinations from anywhere.
  • AI-assisted exams and automated image management improve efficiency and reduce human error.
  • Intuitive and easy-to-use interface, even for non-tech-savvy medical professionals.

Limitations

  • Limited public reviews available on major platforms like G2, Glassdoor, and Capterra specifically for 'Sonio' in the healthcare sector, making a comprehensive analysis challenging.
  • Some search results for 'Sonio' or similar names like 'Sonia' and 'Suno' refer to different companies or products (e.g., student placement software, AI music generation, transcription services), which can lead to confusion.
  • Employer reviews for a company named 'Sonsio' on Indeed mention issues with leadership and job security, but it's unclear if this is the same 'Sonio' company.

Based on reviews from: Medium, G2, The Digitalmehmet Content Ecosystem, Elion Health, Indeed.com, Capterra, Reddit

Last updated: 2026-07-19

Videos

News, demos, and interviews about Sonio.

Loading videos...

Videos load interactively. If none appear, search YouTube for Sonio →

View all on YouTube

Press & Coverage

Sonio
Sonio Announces Official Acquisition By Samsung After French Ministry of the Economy and Finance Approval
Sonio announced its official acquisition by Samsung, a strategic move approved by the French Ministry of the Economy and Finance, aimed at accelerating global growth in maternal care and ultrasound technology. Sonio will continue to operate independently, with its products remaining compatible with all ultrasound device makers.
2024-09
Samsung Medison
Samsung Announces Acquisition of Sonio To Strengthen Its Leading Position in Cutting-Edge Medical Devices
Samsung Medison announced its agreement to acquire 100% of Sonio SAS, a fetal ultrasound AI software company, to enhance women and children's health globally through medical advancements. This acquisition combines Samsung Medison's ultrasound business with Sonio's AI expertise to bring breakthrough AI-enhanced workflows to market.
2024-05
Contemporary OB/GYN
FDA clears Sonio Suspect AI for fetal anomaly detection
The FDA has cleared Sonio's latest prenatal ultrasound AI algorithm, Sonio Suspect, which helps clinicians identify congenital malformations as early as 11 weeks gestation. This technology demonstrated a 22-point improvement in anomaly detection in a multicenter study.
2025-02
Sonio
Sonio Announces FDA Clearance of Sonio Suspect
Sonio announced FDA 510(K) clearance for Sonio Suspect, an AI module designed to enhance prenatal screening with AI-driven anomaly detection and real-time quality control. This solution aims to support early and accurate diagnosis by identifying anomalies across key fetal regions.
2025-02
Sonio
Sonio Announces FDA Clearance of the 3rd version of Sonio Detect
Sonio announced that the third version of its AI-powered solution, Sonio Detect, received FDA 510(k) clearance. This version expands the scope of automatically detected views and anatomical structures, covering up to 65% of ISUOG and AIUM T2/T3 detailed exam protocols.
2026-03
Femtech Insider
Sonio Raises $14M in Series A Funding for Its AI-based Prenatal Screening and Diagnostics Platform
Sonio, a French medtech company, raised $14M in Series A funding led by Cross Border Impact Ventures and Elaia funds. This funding will advance Sonio's SaaS solution, expand its presence in the United States, and adapt its technology for portable ultrasound scanners.
2023-07
Sonio
Sonio secures u20ac10M from the European Innovation Council Accelerator
Sonio secured u20ac10 million through the European Innovation Council (EIC) Accelerator, with u20ac2.5M in grants and u20ac7.5M in equity investment. This funding will further develop its AI-powered platform for fetal anomaly detection and enable expansion into new markets like the USA, Brazil, and India.
2023-05
Sonio Blog
Congenital Malformations: How AI Can Improve Prenatal Ultrasound Detection
Sonio Suspect enables early identification of subtle congenital malformations from as early as 11 weeks, providing a broader diagnostic window for clinicians. Research by Sonio focuses on expanding AI's ability to detect subtle ultrasound findings in clinically important areas, such as congenital CMV.
2026-03

Frequently Asked Questions

Sonio offers a cloud-based AI-powered platform designed to streamline prenatal ultrasound reporting and image management. Its solutions enhance efficiency and quality control for OB/GYN and MFM specialists by automating tasks like data entry, generating customizable reports, and providing real-time feedback on exam completeness and image quality. The platform integrates scanning, reporting, and collaboration into a single workflow, improving overall practice management.
Sonio Detect is an FDA 510(k) cleared and CE Marked AI solution that automatically detects views, anatomical structures, and verifies quality criteria in fetal ultrasound images, ensuring high-quality examinations. Sonio Suspect, also FDA cleared, significantly improves fetal anomaly detection by automatically identifying abnormal findings across key fetal regions as early as 11 weeks' gestation, enhancing reader performance and enabling earlier interventions. Both products combine real-time AI quality control with AI-driven anomaly detection to support accurate diagnosis and exhaustive documentation.
Sonio Detect and Sonio Suspect are both US FDA 510(k) cleared, and Sonio Detect also holds a Class IIa CE Mark under EU Regulation 2017/745. The company adheres to stringent security and data protection standards, including HIPAA compliance, GDPR, HDS certification, ISO 13485 for quality management, and SOC2 Type 2 compliance. Sonio employs robust measures like data encryption, firewalls, and zero-trust security mechanisms to safeguard sensitive medical information.
Sonio's cloud-based platform is vendor-neutral and designed for seamless integration with existing healthcare IT systems, including EHR, PACS, and billing systems, using standards like HL7 and DICOM. This interoperability streamlines digital workflows and allows for automatic population of report fields. Sonio provides implementation and technical support from knowledgeable engineers, along with reliable data backup, storage, and disaster recovery services.
Sonio operates on a Software-as-a-Service (SaaS) model, offering flexible and scalable cloud-based solutions. The company, founded in 2020, demonstrated significant growth, raising $14 million in Series A funding in 2023, and was subsequently acquired by Samsung Medison in 2024 for $92 million, enhancing its stability and global reach. Sonio maintains strategic partnerships with medical institutions, distribution networks, and is compatible with all ultrasound machine manufacturers.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.